SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-19-002091
Filing Date
2019-02-28
Accepted
2019-02-28 16:02:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tgtx-424B5.htm 424B5 595202
2 IMAGE tgtx-preliminaryprospectu000.jpg GRAPHIC 4206
  Complete submission text file 0001654954-19-002091.txt   602445
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218293 | Film No.: 19643107
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences